52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

Links shared publicly online about this topic.

  • 842
    total visits

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

keyvive.com

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To Glipizide Plus Metformin In Improving HbA1c | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com

View full resource at keyvive.com

Tags: Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Phase 3 Clinical Trial, Glucophage, Glucotrol

  • Share

Most Recently Shared on September 27, 2010 at 7:20 pm By:

keyvive Aimee Greenholtz

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar To… http://goo.gl/fb/lVEwI

2 years ago...

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus | Business Wire

businesswire.com — “52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated HemoglobinView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on September 25, 2010 at 7:53 am By:

Urology_Wisdom Urology & Nephrology OW Health

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin ... http://bit.ly/9HYgGl

2 years ago...

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus - Drugs.com MedNews

drugs.com — “Sep 24, 2010 - Bristol-Myers Squibb Company (NYSE BMY) and AstraZeneca (NYSE AZN) today announced results from a randomized, double-blind Phase 3 clinical studyView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on September 24, 2010 at 1:05 pm By:

Drugs_Devices Drugs and Devices OW OW Health

52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metfo... http://bit.ly/accdmv #drug

2 years ago...

Advertisement